Oral contrast for abdominal and pelvic CT: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
For patients undergoing CT of abdomen and/or pelvis | *For patients undergoing CT of abdomen and/or pelvis | ||
*Requires significant "lead time" - i.e. must administer >1hr prior to CT scan | |||
==Redypaque Dose== | ==Redypaque Dose== | ||
| Line 88: | Line 89: | ||
Max = 300cc | Max = 300cc | ||
== | ==Indications== | ||
===Desirable=== | ===Desirable=== | ||
* [[ | * [[Appendicitis]] or [[Diverticulitis]] with BMI <20 | ||
**if CT indicated; consider immediate surgical consultation | **if CT indicated; consider immediate surgical consultation | ||
*[[ | *[[Intra-abdominal abscess]] with concern for a fistula or bowel leak | ||
* | *Suspected fistula or bowel leak | ||
* | *Suspected [[Intussusception]] or internal hernia | ||
===Consider=== | ===Consider=== | ||
* | *Suspected low-grade [[bowel obstruction]] | ||
* | *Intra-abdominal abscess depending on the suspected primary source | ||
** | **May not be required if primary source is skin infection | ||
* | *Metastatic evaluation | ||
* | *Suspected [[Hernia]] | ||
===Not Indicated=== | ===Not Indicated=== | ||
* | *Emergent process needing immediate CT | ||
* | *Delays in time to imaging due to prolonged intolerance of oral contrast | ||
* | *Uncomplicated [[Dppendicitis]] or [[Diverticulitis]] with BMI >20 | ||
* | *Suspected high-grade or severe [[bowel obstruction]] | ||
* | *Suspected aneurysm, dissection, or vessel thrombosis | ||
* | *Suspected bowel ischemia or infarct | ||
*[[ | *[[Nephrolithiasis]] protocol | ||
* | *Pancreatic protocol for [[Pancreatitis]] or mass | ||
* | *Liver protocol for liver mass or abscess | ||
* | *Adrenal protocol for adrenal mass or nodules | ||
* | *Superficial abdominal wall infections or abscesses | ||
*[[ | *[[Inflammatory bowel disease]] | ||
==See Also== | ==See Also== | ||
*[[Contrast | *[[Contrast-induced nephropathy]] | ||
*[[Creatinine | *[[Creatinine screening prior to IV contrast]] | ||
== | ==References== | ||
<references/> | |||
[[Category:Rads]] | [[Category:Rads]] | ||
[[Category:Nephro]] | [[Category:Nephro]] | ||
Revision as of 02:19, 11 August 2015
Background
- For patients undergoing CT of abdomen and/or pelvis
- Requires significant "lead time" - i.e. must administer >1hr prior to CT scan
Redypaque Dose
|
Weight |
Give 1 hour prior to scan |
Give 30 minutes prior to scan |
Give immediately upon arrival to CT |
|
< 2 kg |
None or as ordered by physician |
None or as ordered by physician |
None or as ordered by physician |
|
2-5 kg |
30 mL |
30 mL |
30 mL |
|
>5-20 kg |
90 mL |
90 mL |
90 mL |
|
>20-50 kg |
150 mL |
150 mL |
150 mL |
|
>50 kg |
300 mL |
300 mL |
300 mL |
(100cc/age)/3 = dose x 3
Max = 300cc
Indications
Desirable
- Appendicitis or Diverticulitis with BMI <20
- if CT indicated; consider immediate surgical consultation
- Intra-abdominal abscess with concern for a fistula or bowel leak
- Suspected fistula or bowel leak
- Suspected Intussusception or internal hernia
Consider
- Suspected low-grade bowel obstruction
- Intra-abdominal abscess depending on the suspected primary source
- May not be required if primary source is skin infection
- Metastatic evaluation
- Suspected Hernia
Not Indicated
- Emergent process needing immediate CT
- Delays in time to imaging due to prolonged intolerance of oral contrast
- Uncomplicated Dppendicitis or Diverticulitis with BMI >20
- Suspected high-grade or severe bowel obstruction
- Suspected aneurysm, dissection, or vessel thrombosis
- Suspected bowel ischemia or infarct
- Nephrolithiasis protocol
- Pancreatic protocol for Pancreatitis or mass
- Liver protocol for liver mass or abscess
- Adrenal protocol for adrenal mass or nodules
- Superficial abdominal wall infections or abscesses
- Inflammatory bowel disease
